Post-approval studies (Phase 4)Ended earlyNCT03988842
What this trial is testing
Standard-dose Apixaban AFtEr Very Low-dose ThromboLYSis for Acute Intermediate-high Risk Acute Pulmonary Embolism
Who this might be right for
Pulmonary Embolism With Acute Cor PulmonalePulmonary EmbolismPulmonary Embolism With Pulmonary Infarction+3 more
Victor Tapson, MD 4